A series of monthly calls for ACT psychiatric care providers. Offered in collaboration with the Institute for Best Practices at the University of North Carolina.
Assertive Community Treatment (ACT) is a multidisciplinary, team-based model that provides intensive community-based and outreach-oriented services to people who experience the most severe and persistent mental illness. The vast majority also have a co-occurring substance use disorder and many experience comorbid medical illnesses.
The Northwest MHTTC is hosting a series for ACT psychiatric care providers. We welcome all ACT psychiatrists, nurse practitioners, and other prescribers. Sessions will be held once a month on Thursdays at 12:00-1:30 pm Pacific/3:00-4:30 pm Eastern.
Our second session on June 20th will discuss Clozapine and long-acting injectables (LAI). Learn more about the series and upcoming sessions here.
Dr. Robert O. Cotes is an Associate Professor at Emory University School of Medicine in the Department of Psychiatry and Behavioral Sciences. He serves as Physician Expert for SMI Adviser (www.smiadviser.org), which is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser provides evidence-based resources to clinicians, individuals with serious mental illness, and their families. He is Director of the Clinical & Research Program for Psychosis at Grady Health System, which comprises of three clinical programs. The PSTAR Clinic provides evidence-based, recovery-oriented care for individuals with persistent symptoms of psychosis, specializing in the use of clozapine. Project ARROW is a coordinated specialty care team for people experiencing early psychosis, offering comprehensive, person-centered care using a multidisciplinary approach. Youth and Family TREE provides care to adolescents and young adults with a mental health condition and substance use. Dr. Cotes is an investigator for multiple research studies focused on treatment options for people with psychosis. His research focuses on clozapine and early psychosis.
Donna Rolin, MDDr. Donna Rolin is a Clinical Associate Professor and the Psychiatric Nurse Practitioner program director at the University of Texas at Austin. She is active in the American Psychiatric Nurses Association, where she recently served on the national Board of Directors for five years, and locally in the Psychiatric Advanced Practice Nurses of Austin organization where she serves as president. Dr. Rolin consistently practices and teaches within an inter-disciplinary model. She has held the role of Clinical Nurse Expert on SMI Adviser’s initiative since 2018, which is an initiative funded by SAMHSA and administered by the American Psychiatric Association. She was appointed as Co-Director of the Institute for Domestic Violence and Sexual Assault (IDVSA) in 2016, working alongside the Schools of Social Work, Law, and Bureau of Business Research. She recently presented research in England and Scotland with the IDVSA Director on longitudinal mental health outcomes related to campus sexual assault and best practices for establishing a medical home for international survivors of human trafficking, respectively. She practices as a Psychiatric Mental Health Nurse Practitioner with a community-based group working with underserved patients with serious mental illnesses and intellectual disabilities in community/ residential facilities. Dr. Rolin’s recent national and regional professional conference presentations focus on topics such as substance use disorders, psychiatric differential diagnoses, psychopharmacology, measurement-based care, and clinician burnout. Dr. Rolin is Co-PI on an Integrated Behavioral Health Scholars initiative funded through a HRSA Behavioral Health Workforce Education and Training (BHWET) program and as consultant on a HRSA Graduate Psychology Education (GPE) grant
